CClinicalTrials.gg
RecruitingNCT07199374ParcaUpdated Sep 30, 2025

PARCA (a Digital Tool) to Improve Justice and Health

An interventional study of PARCA in Behavioral Addiction, sponsored by George Mason University. Recruiting at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-30.

Sponsored by George Mason University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Mar 2025; still recruiting 1 year 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to assess the effectiveness of the Probation/Parole and Reentry Coach Application (PARCA)-a mobile application that allows justice-involved people to set and manage personal goals to support sustained, successful community supervision. Through this study, we aim to conduct surveys and interviews aimed to gain a better understanding of ways to improve the substance use treatment process, connections between clients and officers, and goal selection and achievement for clients using the PARCA app

Read the detailed description

This study tests a new technological intervention referred to as Probation/Parole and Reentry Coach Application (PARCA). The application uses motivational interviewing and cognitive behavioral techniques to engage clients in problem solving by identifying issues, identifying goals, making progress towards the goals, incentivizing clients to achieve the goals, and working towards completion of supervision. Officers can view the goals, progress, and points accumulated to improve supervision outcomes.

02

Conditions studied

  • Behavioral Addiction

Keywords

  • probation supervision
  • recovery app
03

In context

Lead sponsor

George Mason University is the lead sponsor of 41 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

All officers that supervise individuals All individuals on supervision that indicate drug use -

Exclusion criteria

Exclusion Criteria:

Individuals that have poor performance on their job clients have serious mental health disorders

-

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    PARCA App

    Officers and clients are using the application of PARCA which is on their phone and a web-based application. PARCA is a tool to detail goals and progress towards goals

    Behavioral: PARCA

  • No intervention
    Standard Supervision

    Officers and clients are not using any new procedures or tools; they are using standard care.

Interventions

  • BehavioralPARCA

    PARCA is an s an app to facilitate goal management, resource allocation, and managing progress.

06

What researchers measure

Primary outcomes

  1. Number of Days till the Individual Initiates Treatment

    This represents the number of days that the individual starts treatment based on the day that they started supervision. This can be measured in the supervision records. This is an event in the record system like an electronic health record.

    Time frame: The timeframe is 365 days

Secondary outcomes

  1. Number of Treatment Sessions in 90 days

    This represents the number of times the individual participated in treatment during a 90 day window. This can be measured from supervision records.

    Time frame: For 365 days

Other outcomes

  1. Drug Tests

    Test positive for an illicit drug

    Time frame: through study completion, an average of 1 year

  2. Number of times the individual has been arrested or technically violated probation

    This criminal justice outcome refers to other criminal behavior and/or failure to abide by supervision conditions. Both reflect events that can be measured in the supervision records.

    Time frame: This is for 365 days

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — These are confidential

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07199374
Lead sponsor
George Mason University
Collaborators
Q2i, LLC, RTI International, Worcester Polytechnic Institute, National Institute on Drug Abuse (NIDA)
Responsible party
Sponsor
First posted
Sep 30, 2025
Start date
Mar 1, 2025
Primary completion
May 2027 (estimated)
Completion
May 2027 (estimated)
Last update
Sep 30, 2025

Study contacts

Faye S Taxman, Ph.D.
Contact
ftaxman@gmu.edu
7039938555
Faye S. Taxman, PhD
principal investigator · George Mason University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion